Infection Due to Coronary Artery Bypass Graft (Diagnosis)NCT07003750
Surgical Wound Infection Prevention Bundle in Patients Undergoing Coronary Bypass Graft Surgery
A study testing Surgical wound infection prevention bundle in people with Infection Due to Coronary Artery Bypass Graft (Diagnosis), run by Sohag University at 1 site in Egypt.
Trial summary
estimate the utilization of locally customized surgical wound infection bundle to prevent and or control of infection in patients undergoing CABG surgery in Sohag Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Infection Due to Coronary Artery Bypass Graft (Diagnosis)
- What is being tested?
- Surgical wound infection prevention bundle
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jul 2025to 30 Jun 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- coronary artery disease ,diebetes mellitus,hypertension,
Who cannot join
- patients who have cancer , immunocompromised patients, cardiac surgeries other than CABG
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Surgical Wound Infection Prevention Bundle in Patients Undergoing Coronary Bypass Graft Surgery Sohag Experience
estimate the utilization of locally customized surgical wound infection bundle to prevent and or control of infection in patients undergoing CABG surgery in Sohag
- Being tested
- Surgical wound infection prevention bundle
- Medical subject headings
- Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Surgical wound infection prevention bundleOther
utilization of locally customized surgical wound infection bundle to prevent and or control of infection in patients undergoing CABG surgery
| Study group | Role | What they receive |
|---|---|---|
| group 1 | Active comparator | * Preoperative:
1. Nightly CHG baths
2. Mupirocin nasal ointment twice daily for 2 to 5 days prior to surgery
3. Hair removal with clippers
* Intraoperative:
1. Skin antisepsis with CHG solution
2. Standardized IV antibiotic doses at the following time points :within 5 to 60 minutes of the initial surgical incision, with initiation of cardiopulmonary bypass ,and every 3 hours intraoperatively for the duration of the case.
* Postoperative :
1. The occlusive sternal dressing applied at time of chest closure and removed 48 hours postoperatively then daily dressing thereafter.
2. Daily postoperative linen change and minimize sternotomy exposure to home blankets Receives: Other: Surgical wound infection prevention bundle |
| group 2 | No intervention | * Preoperative: 1. Preoperative water and soap bath 2. Hair removal with razor * Intraoperative: 1. Skin antisepsis with betadine solution 2. One dose of antibiotic just before skin incision * Postoperative: 1. The occlusive sternal dressing removed 72 hours postoperatively then daily dressing 2. No specific concerns about linens change and home blankets exposure |
What is being measured
The primary outcome is the main question the study is designed to answer.
surgical site wound infection
Early complications including superficial and deep surgical site infection. Late complications including DSWI, systemic and chronic sinus
Measured: From enrollment to 6 months after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Jun 2025
- Study start1 Jul 2025
- Primary completion30 Mar 2026
- Study completion30 Jun 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Infection Due to Coronary Artery Bypass Graft (Diagnosis)Studies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Ragab Mostafa, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07003750
- Sponsor's protocol ID
- soh-Med--25-4-05MS
- Status last verified
- Jul 2026
- First submitted
- 8 May 2025
- Last updated
- 9 Jul 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Surgical Wound Infection Prevention Bundle in Patients Undergoing Coronary Bypass Graft Surgery Sohag Experience
- ClinicalTrials.gov ID
- NCT07003750
- Acronym / sponsor ID
- soh-Med--25-4-05MS
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 1 Jul 2025 (actual)
- Primary completion
- 30 Mar 2026 (actual)
- Study completion
- 30 Jun 2026 (actual)
- First posted
- 4 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
estimate the utilization of locally customized surgical wound infection bundle to prevent and or control of infection in patients undergoing CABG surgery in Sohag
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| group 1 | Active comparator | Other: Surgical wound infection prevention bundle* Preoperative: 1. Nightly CHG baths 2. Mupirocin nasal ointment twice daily for 2 to 5 days prior to surgery 3. Hair removal with clippers * Intraoperative: 1. Skin antisepsis with CHG solution 2. Standardized IV antibiotic doses at the following time points :within 5 to 60 minutes of the initial surgical incision, with initiation of cardiopulmonary bypass ,and every 3 hours intraoperatively for the duration of the case. * Postoperative : 1. The occlusive sternal dressing applied at time of chest closure and removed 48 hours postoperatively then daily dressing thereafter. 2. Daily postoperative linen change and minimize sternotomy exposure to home blankets |
| group 2 | No intervention | –* Preoperative: 1. Preoperative water and soap bath 2. Hair removal with razor * Intraoperative: 1. Skin antisepsis with betadine solution 2. One dose of antibiotic just before skin incision * Postoperative: 1. The occlusive sternal dressing removed 72 hours postoperatively then daily dressing 2. No specific concerns about linens change and home blankets exposure |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- coronary artery disease ,diebetes mellitus,hypertension,
Key exclusion criteria (1 listed)
- patients who have cancer , immunocompromised patients, cardiac surgeries other than CABG
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Surgical wound infection prevention bundleutilization of locally customized surgical wound infection bundle to prevent and or control of infection in patients undergoing CABG surgery | Other | group 1 |
Primary outcome
surgical site wound infection
Time frame: From enrollment to 6 months after surgery
Early complications including superficial and deep surgical site infection. Late complications including DSWI, systemic and chronic sinus
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jul 2026.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Surgical wound infection prevention bundle in people with Infection Due to Coronary Artery Bypass Graft (Diagnosis), run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
surgical site wound infection (time frame: From enrollment to 6 months after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2026; AzTrials last refreshed its copy on 6 Nov 2026.